Based on ratings from 0 stock analysts, the Flora Growth Corp. stock price is expected to increase by 376.19% in 12 months. This is calculated by using the average 12-month stock price forecast for Flora Growth Corp.. The lowest target is $5 and the highest is $5. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedFLGC 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Flora Growth Corp. to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on FLGC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of FLGC.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Aaron Grey Alliance Global Partners | Neutral | Downgrade | Aug 15, 2024 | |
Bill Kirk Roth MKM | Buy | $6 | Reiterates | May 16, 2024 |
William Kirk Roth MKM | Buy | $7 | Maintains | Apr 3, 2024 |
Roth MKM | Buy | Maintains | Jun 1, 2023 | |
Bill Kirk Roth MKM | Buy | $1 | Maintains | May 18, 2023 |
Roth MKM | Buy | Maintains | Apr 19, 2023 | |
Steve Silver Argus Research | Buy | $3 | Maintains | Feb 1, 2023 |
Aaron Grey Alliance Global Partners | Buy | $2 | Maintains | Oct 25, 2022 |
Aaron Grey Alliance Global Partners | Buy | $2.5 | Initiates | Sep 23, 2022 |
Pablo Zuanic Cantor Fitzgerald | Neutral | $0.85 | Initiates | Aug 1, 2022 |
Roth Capital | Buy | Initiates | Oct 13, 2021 | |
MKM Partners | Buy | Initiates | Jun 23, 2021 |
When did it IPO
2021
Staff Count
97
Country
United States
Sector/Industry
Healthcare/Drug ManufacturersโSpecialty & Generic
CEO
Mr. Clifford A. Starke
Market Cap
$16.5M
In 2023, FLGC generated $76.1M in revenue, which was a increase of 127.75% from the previous year. This can be seen as a signal that FLGC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
No news data available.